Essex Bio-Technology Limited (HKG:1061)
Hong Kong
· Delayed Price · Currency is HKD 3.950
+0.080 (2.07%)
At close: Mar 10, 2026
Essex Bio-Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,194 | 1,667 | 1,413 | 2,401 | 2,848 | 2,463 | Upgrade
|
| Market Cap Growth | 45.49% | 17.98% | -41.13% | -15.72% | 15.63% | -32.35% | Upgrade
|
| Enterprise Value | 1,843 | 1,394 | 1,349 | 2,272 | 2,753 | 2,432 | Upgrade
|
| Last Close Price | 3.87 | 2.86 | 2.32 | 3.83 | 4.41 | 3.74 | Upgrade
|
| PE Ratio | 7.03 | 5.43 | 5.13 | 10.65 | 8.23 | 11.25 | Upgrade
|
| Forward PE | 6.79 | 3.14 | 3.62 | 6.39 | 7.95 | 11.26 | Upgrade
|
| PS Ratio | 1.28 | 1.00 | 0.81 | 1.82 | 1.74 | 2.52 | Upgrade
|
| PB Ratio | 0.97 | 0.79 | 0.74 | 1.39 | 1.64 | 1.73 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.41 | 1.36 | 2.73 | 2.64 | 2.61 | Upgrade
|
| P/FCF Ratio | 8.66 | 5.15 | 4.44 | 8.19 | 8.93 | 12.19 | Upgrade
|
| P/OCF Ratio | 6.11 | 4.53 | 4.17 | 6.27 | 6.96 | 8.23 | Upgrade
|
| PEG Ratio | - | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | Upgrade
|
| EV/Sales Ratio | 1.07 | 0.84 | 0.78 | 1.72 | 1.68 | 2.49 | Upgrade
|
| EV/EBITDA Ratio | 4.21 | 3.48 | 3.35 | 6.76 | 6.57 | 8.88 | Upgrade
|
| EV/EBIT Ratio | 4.76 | 3.93 | 3.84 | 7.52 | 6.99 | 9.67 | Upgrade
|
| EV/FCF Ratio | 7.27 | 4.30 | 4.24 | 7.75 | 8.63 | 12.03 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.09 | 0.15 | 0.28 | 0.33 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 0.66 | 0.46 | 0.72 | 1.45 | 1.34 | 2.04 | Upgrade
|
| Debt / FCF Ratio | 1.15 | 0.58 | 0.92 | 1.67 | 1.77 | 2.78 | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.18 | -0.11 | -0.03 | -0.06 | -0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.81 | -0.93 | -0.55 | -0.16 | -0.25 | -0.13 | Upgrade
|
| Net Debt / FCF Ratio | -1.39 | -1.15 | -0.69 | -0.18 | -0.33 | -0.18 | Upgrade
|
| Asset Turnover | 0.55 | 0.57 | 0.63 | 0.47 | 0.62 | 0.44 | Upgrade
|
| Inventory Turnover | 2.35 | 2.14 | 2.07 | 1.34 | 1.83 | 1.32 | Upgrade
|
| Quick Ratio | 1.72 | 1.62 | 1.37 | 1.81 | 1.95 | 1.79 | Upgrade
|
| Current Ratio | 1.90 | 1.81 | 1.54 | 2.16 | 2.24 | 2.20 | Upgrade
|
| Return on Equity (ROE) | 14.60% | 15.18% | 15.06% | 13.01% | 21.89% | 16.69% | Upgrade
|
| Return on Assets (ROA) | 7.83% | 7.63% | 7.93% | 6.77% | 9.31% | 6.99% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.58% | 16.81% | 16.55% | 15.82% | 22.89% | 17.77% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.70% | 15.60% | 17.40% | 14.00% | 18.10% | 13.90% | Upgrade
|
| Earnings Yield | 14.27% | 18.43% | 19.48% | 9.39% | 12.15% | 8.89% | Upgrade
|
| FCF Yield | 11.55% | 19.44% | 22.51% | 12.22% | 11.20% | 8.21% | Upgrade
|
| Dividend Yield | 3.62% | 4.19% | 3.88% | 1.70% | 2.16% | 1.34% | Upgrade
|
| Payout Ratio | 21.73% | 19.39% | 14.50% | 24.19% | 15.00% | 13.20% | Upgrade
|
| Buyback Yield / Dilution | 4.11% | 2.24% | 0.62% | 0.43% | 0.21% | 0.12% | Upgrade
|
| Total Shareholder Return | 7.59% | 6.43% | 4.50% | 2.13% | 2.37% | 1.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.